GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » EV-to-EBITDA

Acepodia (ROCO:6976) EV-to-EBITDA : -12.74 (As of May. 23, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Acepodia EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Acepodia's enterprise value is NT$9,742.87 Mil. Acepodia's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-764.52 Mil. Therefore, Acepodia's EV-to-EBITDA for today is -12.74.

The historical rank and industry rank for Acepodia's EV-to-EBITDA or its related term are showing as below:

ROCO:6976' s EV-to-EBITDA Range Over the Past 10 Years
Min: -16.23   Med: -13.58   Max: -11.82
Current: -12.75

During the past 4 years, the highest EV-to-EBITDA of Acepodia was -11.82. The lowest was -16.23. And the median was -13.58.

ROCO:6976's EV-to-EBITDA is ranked worse than
100% of 448 companies
in the Biotechnology industry
Industry Median: 10.08 vs ROCO:6976: -12.75

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Acepodia's stock price is NT$27.75. Acepodia's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-2.440. Therefore, Acepodia's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Acepodia EV-to-EBITDA Historical Data

The historical data trend for Acepodia's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia EV-to-EBITDA Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
- - - -17.53

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial - - - - -17.53

Competitive Comparison of Acepodia's EV-to-EBITDA

For the Biotechnology subindustry, Acepodia's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acepodia's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acepodia's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Acepodia's EV-to-EBITDA falls into.



Acepodia EV-to-EBITDA Calculation

Acepodia's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=9742.872/-764.519
=-12.74

Acepodia's current Enterprise Value is NT$9,742.87 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acepodia's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-764.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acepodia  (ROCO:6976) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Acepodia's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=27.75/-2.440
=At Loss

Acepodia's share price for today is NT$27.75.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acepodia's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-2.440.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Acepodia EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Acepodia's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Acepodia (ROCO:6976) Business Description

Traded in Other Exchanges
N/A
Address
17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia (ROCO:6976) Headlines

No Headlines